Novavax Logo
US6700024010
A2PKMZ
NVAX

Novavax

Analyses

Rating Analysis
(2)
Novavax Aktie: Mega-Chance durch Impfstoff-Zulassung?
On January 3rd, 2022 by FinMent
View analysis

Curated by Aktienfinder

🍪

Parqet  uses cookies. Learn more